Live Satellite Symposium at the ACTRIMS 2017 Forum

Live Satellite Symposium
at the ACTRIMS 2017 Forum

The Emerging Role of Selective S1P-Based Therapeutics in the Management of Patients with Multiple Sclerosis

Date

February 24, 2017
7:00 am to 8:15am

Location

Omni ChampionsGate
Orlando, Florida
Now Open
actrims_logo_450-glow

Overview

This live, interactive satellite symposium at the ACTRIMS Forum 2017 will highlight recent updates in Sphingosine-1-Phosphate Science (S1P) for the treatment of patients with multiple sclerosis. Five expert faculty will analyze clinical trial data regarding selective S1P-based therapeutics and review methods of utilization for the management of patients with MS. Optimal shared decision making strategies, particularly in regards to patient education techniques, will be discussed. Faculty will provide the learners with a better understanding of best practices for implementing recent data in practice.

Target Audience

Neurologists, and other healthcare professionals who care for patients with multiple sclerosis.

Learning Objectives

  1. Understand the science and mode of action of selective sphingosine-1-phosphate therapeutics.
  2. Analyze current and emerging clinical trial data for selective S1P-based therapeutics for the management of patients with MS.
  3. Apply selective S1P therapeutics to treatment plans for patient’s with multiple sclerosis.

 

Agenda

Welcome and Introductions – Fred D. Lublin, MD

1. Sphingosine-1-Phosphate Science – Jack Antel, MD

– The Current Understanding of Immunopathology in MS

– Review Therapeutic Targets in Multiple Sclerosis

– Emerging Selective S1P Receptor Modulators

2. Clinical Trial Update for Selective S1P Receptor Modulators – Mark Freedman, MD

– Efficacy and Safety Data for Selective S1P-based Therapeutics

– Measuring Efficacy-Relapse Rates, Primary Endpoints and NEDA

3. Practical Assessment of Benefit vs. Risk for Patients Treated with S1P Therapeutics – Joseph Berger, MD & Amy Perrin Ross APN, MSN, CNRN, MSCN

– What We Know About Infectious Disease Risk in S1P Therapies

– Shared Decision Making Through Patient Education

Panel Discussion and Conclusion – Fred D. Lublin, MD

Location

Omni ChampionsGate
1500 Masters Boulevard
ChampionsGate, FL 33896
(407) 390-6664

 

Registration Fees

This is a complementary CME symposium.

Accreditation Statement

AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AcademicCME is an accredited provider of continuing nursing education by the American Nursing Credentialing Center’s Commission on Accreditation.

 

Credit Designation Statement

AcademicCME designates this live activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AcademicCME designates this live activity for a maximum of 1.25 Credit Hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

 

CE Inquiries/Special Needs

For all CE inquiries or special needs, please contact: [email protected].

 

Financial Support

This activity has been supported by an independent educational grant from Celgene Corporation.

 

Provided By

screen-shot-2016-12-01-at-11-31-00-am

Program Chair

Fred D. Lublin, MD

Saunders Family Professor of Neurology
Director, Corinne Goldsmith Dickinson Center for MS
Icahn School of Medicine at Mount Sinai
New York, New York

Faculty

Jack Antel, MD

Professor
Montreal Neurological Institute and Hospital
McGill University
Montreal, QC

Joseph R. Berger, MD, FACP, FAAN, FANA

Professor of Neurology and MS Division Chief
Department of Neurology, Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA

fredman

Mark S. Freedman, MD

Professor of Medicine
University of Ottawa
Senior Scientist
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada

 

perrin

Amy Perrin Ross, APN, MSN, CNRN, MSCN

Neuroscience Program Coordinator
Loyola University Medical Center
Maywood, Illinois

 

The Americas Committee for Treatment and Research in Multiple Sclerosis is pleased to welcome you to the second annual stand-alone meeting: ACTRIMS Forum 2017

The Americas Committee for Treatment and Research in Multiple Sclerosis is pleased to welcome you to the second annual stand-alone meeting: ACTRIMS Forum 2017! ACTRIMS Forum 2017 promises to be of value to physicians, scientists, researchers, analysts, faculty, fellows and allied health professionals examining the advances in research and treatment of MS on the care of patients. Hosted at the Omni ChampionsGate in Orlando, Florida, February 23-25, this Forum will focus on Environmental Factors, Genetics, and Epigenetics in MS Susceptibility and Clinical Course. In addition to great information, ACTRIMS Forum 2017 will provide unique networking opportunities with some of the top researchers in the field of MS.

For more information: www.actrims.org/forum2017 Register today.